From BlockchainDataWiki
Jump to: navigation, search
Ico logo aenco.jpg Global Healthtech Blockchain Financial Solutions
Rating 4.3
Team Vision Product
4.1 3.7 3.7


The World's First Blockchain-Based Healthcare Financial Solutions and Application Development Platform.

Token AEN
Price 1 AEN = 0.1 USD
Bonus Available
Platform Ethereum
Type ERC223
Accepting BTC, ETH
Minimum investment 1 ETH
Distributed in ICO 15%
Soft cap 15,000,000 USD
Hard cap 60,000,000 USD
Tokens for sale 600000000
Country Samoa
Restricted areas USA, China
preICO start preICO end ICO start ICO end
2018-07-27 00:00:00 2018-08-31 00:00:00 2018-09-01 00:00:00 2018-09-30 00:00:00


Aenco is a blockchain based global financial solutions platform, combining decades of experience in traditional financial services and prime brokerage, with network of Healthcare technology (“HealthTech”) innovation partners and new-age applications, collectively developed under the umbrella “Aenco Global HealthTech Financial Solutions platform”.

What is special about Aenco?

Aenco is the world’s FIRST Blockchain based Healthcare Technology Financial Solutions Platform that leverages healthcare technologies with institutional financing, prime brokerage and smart capital solutions under one umbrella.

Aenco is a “one stop shop” for the delivery of cutting edge institutional financing, prime brokerage and core smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development.

Aenco will be combining its solutions platform and core financial ecosystem with the wider healthcare technology community, through the AEN token, as the key ecosystem building block and extensions across ALL its service and community deliveries.

The Aenco platform empowers emerging and innovative healthcare companies with digital financing capabilities, so that they can focus on generating high potential and impactful technologies that can transform our world and day to day lives.

Aenco is supported by the group’s planned regulated infrastructure (including the establishment of a commercial bank within the group) and presence in major jurisdictions including Europe, Hong Kong, and the United States, through which Aenco will effectively deliver its solutions, generating an increasing and rapidly evolving ecosystem.


Team photo 3681-43672.jpg
Ian Huen
Team photo 3681-43673.jpg
Darren Lui
Team photo 3681-43674.jpg
Kenrick Fok

Team photo 3681-43675.jpg
Geoff Tipy
Team photo 3681-43676.jpg
Charles Lau
Managing Director
Team photo 3681-43677.jpg
Erica Chan
Head of Wealth Management

Team photo 3681-43678.jpg
Isabella Lai
Senior Director
Team photo 3681-43679.jpg
Teddy Ip
Senior Director
Team photo 3681-43680.jpg
Nick Wan
Co-Investment Director

Team photo 3681-43681.jpg
Calvin Poon
Co-Investment Director
Team photo 3681-43682.jpg
Ally Cheung
Head of Community Management
Team photo 3681-43683.jpg
David Carey
Senior Cloud Engineer

Team photo 3681-43684.jpg
Aaron Regala
Business Analyst
Team photo 3681-43685.jpg
Andy Chan
Head of Insurance
Team photo 3681-43686.jpg
Issac Cheung
Full Stack Developer


Team photo 3681-43687.jpg
Douglas W. Arner
Senior Regulatory and Strategic Advisor
Team photo 3681-43688.jpg
Virginia Lam
Marketing Advisor
Team photo 3681-43689.jpg
Douglas Ching
Marketing Advisor

Team photo 3681-43690.jpg
S.M. Yiu
Team photo 3681-43691.jpg
Jeff Marquass
Team photo 3681-43692.jpg
Albert Leung

Team photo 3681-43693.jpg
Kenny Yu
Team photo 3681-43694.jpg
Kwok Ka Wai
Team photo 3681-43695.jpg
Owen Ko

Team photo 3681-43696.jpg
Sunny Wong
Team photo 3681-43697.jpg
William Wu
Team photo 3681-43698.jpg
Joe Hui

Team photo 3681-43699.jpg
Julian Ting
Team photo 3681-43700.jpg
Shell Cheung


  1. 2005
    Aeneas Capital grante Asset Management license by SFC (Hong Kong).
  1. 2008-2009
    Fund products generate positive returns throughout subprime crisis.
  1. 4Q 2010
    Assets managed by Aeneas deployed into health care private equity and direct investments.
  1. 2Q 2016
    Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
  1. 3Q 2017
    Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities;
    Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
  1. 1Q 2018
    Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress);
    Aeneas Group establishing a full-service banking license in Europe (in progress).
  1. 2Q 2018
    June Initiate Private Sale;
    Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities;
    Community investors outreach.
  1. 4Q 2018
    Expand team: Developers;
    1st pipeline healthtech;
    ICO launch;
    Launch first generation smart wallet & infrastucture (AEN Connect).
  1. 4Q 2019
    Second generation: AENX trading exchange.
  1. 2Q 2020
    Third generation: AENCO prime brokerage platform;
    Ongoing service & expansion of pipeline HealthTech partners.


Expert photo karavaev-1512904655.jpg

Igor Karavaev - ico advisor and investor
Rated on 2018-06-14

The economics of token is very unclear. It is explained that this is sort of membership reward token. But it still looks vague how the price could grow. I am not claiming to speak directly about such things in the whitepapers due to the well-known restrictions. But at least the project should add business numbers numbers about "ecosystem growth" in chapter 8 of the WP.

Team Vision Product
5 3 4

Expert photo tran-van-tinh-1522114061.jpg

Tinh Tran - ICO Advisor | ICO Communications Expert
Rated on 2018-07-05

Team: Most of your advisors are not having a linked profile which make investors feel uncertain of their investment. Need to add more verified advisors to convince investors.

Vision: If you are doing this right as an ecosystem, it can be a good idea but I don't see it clearly stated in the whitepaper.

Product is vague as github does not considered a MVP as most of investors care about their ROI and having low tech knowledge.

Team Vision Product
3 4 3

Expert photo giovanni-casagrande-1520259705.jpg

Giovanni Casagrande - ICO Advisor and Growth Hacker
Rated on 2018-07-09

I think the team is fairly strong and I like the vision. Supply chain in Health is critical.
The WhitePaper is not clear enough, but they they can change healthcare world.
Good idea, good team, well thought out, well done.

Team Vision Product
4 4 4

Expert photo kenneth-tam-1528088290.jpg

Kenneth Tam - Crypto Investor | ICO Advisor | Token Sale Marketing | Private Sale Consultant
Rated on 2018-07-13

One of a few ICOs that builds and expands on an existing successful business in Fintech field. The core team has extensive and solid investment and capital background, plus the advisers are reputable in healthcare and medical fields, in the aspect of their research and technology innovation. That makes it a good-matched project combination of “when FinTech meets HealthTech”.

The Whitepaper is a bit complicated, to be honest, with layers of “not-so-easy-to-understand” stereoscopic concepts, proficient medical terms and sophisticated financial wordings, while this project is going to be managed and operated by trained professionals and industrial leaders, not amateurs, where it gains much confidence for investors.

Highly recommended ICO and an excellent Whitepaper!

Team Vision Product
5 5 5

Expert photo benchy.jpg

Benchy - ICO Analyzer Bot
Rated on 2018-10-19

Team Vision Product
0 0 0